Cargando…
Kinetics of the viral cycle influence pharmacodynamics of antiretroviral therapy
BACKGROUND: More and more antiretroviral therapies are being developed for treatment of HIV infection. The in-vivo efficacy of these drugs is commonly predicted based on in-vitro measures of antiviral effect. One primary in-vitro measure is the IC50, the amount of drug required for 50% inhibition of...
Autores principales: | Sedaghat, Ahmad R, Wilke, Claus O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203257/ https://www.ncbi.nlm.nih.gov/pubmed/21910865 http://dx.doi.org/10.1186/1745-6150-6-42 |
Ejemplares similares
-
Low-level HIV-1 replication and the dynamics of the resting CD4(+ )T cell reservoir for HIV-1 in the setting of HAART
por: Sedaghat, Ahmad R, et al.
Publicado: (2008) -
Viral Decay Kinetics in the Highly Active Antiretroviral Therapy-Treated Rhesus Macaque Model of AIDS
por: Deere, Jesse D., et al.
Publicado: (2010) -
Influence of food on pharmacokinetics and pharmacodynamics of 4-phenylbutyrate in patients with urea cycle disorders
por: Nakajima, Yoko, et al.
Publicado: (2021) -
Influence of provider experience on antiretroviral adherence and viral suppression
por: Horberg, Michael A, et al.
Publicado: (2012) -
Phenotypic mixing and hiding may contribute to memory in viral quasispecies
por: Wilke, Claus O, et al.
Publicado: (2003)